DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer

Montrouge, France, October 16, 2023

DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the appointment of Virginie Boucinha as its Chief Financial Officer, effective November 6, 2023. An experienced financial and operations executive, Virginie will report directly to Daniel Tassé, Chief Executive Officer, and serve as a member of the Executive Committee.

“I am pleased to welcome Virginie to the DBV Executive Committee to lead our global financial organization,” said Daniel Tassé, Chief Executive Officer, DBV Technologies. “Virginie is collaborative, results-focused, and brings extensive experience in finance, strategy, and global management across the pharmaceutical industry. I know she will bring great value to our leadership team.”

Virginie will be responsible for DBV’s financial management and operations, information technology, strategic planning, and investor relations. Virginie brings approximately 30 years of diverse experience in the pharmaceutical industry. She most recently served as the Group Performance Director for Pierre Fabre. Prior to this, Virginie held various senior positions at Sanofi, including Chief of Staff to the Sanofi CEO, Global Transformation Office Head, and Chief Financial Officer for India and South Asia. She is trained in finance as a graduate of Ecole Superieure de Gestion where she obtained a Master of Business Administration. Virginie will be based at DBV’s headquarters in Montrouge, France.

“I am thrilled to be joining DBV Technologies at such a critical juncture,” said Ms. Boucinha. “The Company is swiftly advancing two, distinct BLAs for Viaskin in toddlers and children living with a peanut allergy. It is imperative that DBV maintains the same financial discipline that our shareholders have come to expect, while wisely positioning the Company for regulatory and commercial success. I am looking forward to this mission and to collaborating alongside the broader DBV Executive team.”

Sébastien Robitaille, Chief Financial Officer, DBV Technologies, will be leaving the Company to pursue other opportunities on November 17^th. Virginie will onboard on November 6, 2023, allowing for a smooth two-week transition between executives.

“I am thankful to Sébastien for his many contributions to DBV over the years,” said Mr. Tassé. “We are fortunate to have had his guidance on the Executive Committee. As DBV’s Chief Financial Officer, Sébastien helped facilitate our corporate restructuring and upheld financial discipline. We are a more agile and flexible organization thanks to his work. I wish him the very best in his next endeavors.”